These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2710414)

  • 21. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 22. Habenular lesion attenuates methamphetamine-induced inhibition of dopamine neuronal activity in the substantia nigra pars compacta of rats.
    Sasaki K; Suda H; Watanabe H; Kaneko S; Nomura Y; Nishino H; Ono T
    Neurosci Lett; 1988 Mar; 86(1):67-71. PubMed ID: 3362431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology.
    Grace AA; Bunney BS
    Brain Res; 1985 May; 333(2):285-98. PubMed ID: 3995296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of effect of intranigral administration of a dopamine analogue, (+/-)-3-(3-hydroxyphenyl)-N,n-propylpiperidine [(+/-)-3-PPP], on nigrostriatal dopamine neurones.
    Kelly E; Jenner P; Marsden CD
    Neurosci Lett; 1985 May; 56(1):57-62. PubMed ID: 4011049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of the entopeduncular nucleus and the habenula in methamphetamine-induced inhibition of dopamine neurons in the substantia nigra of rats.
    Sasaki K; Suda H; Watanabe H; Yagi H
    Brain Res Bull; 1990 Jul; 25(1):121-7. PubMed ID: 2207698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiological and pharmacological evidence for the existence of distinct subpopulations of nigrostriatal dopaminergic neuron in the rat.
    Shepard PD; German DC
    Neuroscience; 1988 Nov; 27(2):537-46. PubMed ID: 3217003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 5-HT3 receptor antagonists LY 277359 and granisetron potentiate the suppressant action of apomorphine on the basal firing rate of ventral tegmental dopamine cells.
    Minabe Y; Ashby CR; Schwartz JE; Wang RY
    Eur J Pharmacol; 1991 Dec; 209(3):143-50. PubMed ID: 1665793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Denervation-like postsynaptic supersensitivity to dopamine agonists induced by microinjection of colchicine into the substantia nigra pars compacta.
    Kamata K; Kameyama T; Okuyama S; Hashimoto S; Aihara H
    Brain Res; 1986 Mar; 367(1-2):1-7. PubMed ID: 3008917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of nigral dopaminergic firing by N-n-propyl-norapomorphine: behavioural and biochemical correlates.
    Mereu G; Argiolas A; Melis MR; Gessa GL
    Ann Ist Super Sanita; 1982; 18(1):57-61. PubMed ID: 6892092
    [No Abstract]   [Full Text] [Related]  

  • 31. Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration.
    Kelland MD; Freeman AS; Chiodo LA
    Synapse; 1989; 3(1):30-7. PubMed ID: 2919369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pertussis toxin lesions of the rat substantia nigra block the inhibitory effects of the gamma-hydroxybutyrate agent, S(-)HA-966 without affecting the basal firing properties of dopamine neurons.
    Shepard PD; Connelly ST
    Neuropsychopharmacology; 1999 Nov; 21(5):650-61. PubMed ID: 10516961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flunarizine attenuates cocaine-induced inhibition of A9 dopaminergic neurons.
    Diana M; Pani L; Rossetti Z; Passino N; Gessa GL
    Pharmacol Res; 1991 Aug; 24(2):197-203. PubMed ID: 1661005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Firing properties of substantia nigra dopaminergic neurons in freely moving rats.
    Freeman AS; Meltzer LT; Bunney BS
    Life Sci; 1985 May; 36(20):1983-94. PubMed ID: 3990520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranigral injection of the H3 agonist immepip and systemic apomorphine elicit ipsilateral turning behaviour in naive rats, but reduce contralateral turning in hemiparkinsonian rats.
    García-Ramírez M; Aceves J; Arias-Montaño JA
    Behav Brain Res; 2004 Oct; 154(2):409-15. PubMed ID: 15313028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nigral dopaminergic neurons: differential sensitivity to apomorphine following long-term treatment with low and high doses of amphetamine.
    Kamata K; Rebec GV
    Brain Res; 1984 Oct; 321(1):147-50. PubMed ID: 6498510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lesions of substantia nigra by kainic acid: effects on apomorphine-induced stereotyped behaviour.
    Morelli M; Porceddu ML; Di Chiara G
    Brain Res; 1980 Jun; 191(1):67-78. PubMed ID: 7189684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased burst firing in substantia nigra pars reticulata neurons and enhanced response to selective D2 agonist in hemiparkinsonian rats after repeated administration of apomorphine.
    Lee JI; Shin HJ; Nam DH; Kim JS; Hong SC; Shin HJ; Park K; Eoh W; Kim JH; Lee WY
    J Korean Med Sci; 2001 Oct; 16(5):636-42. PubMed ID: 11641536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.